Inspire Medical Systems, Inc. (INSP)

From the record

Inspire Medical Systems, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Inspire Medical Systems, Inc.'s 8 filed years say what it did: revenue went from $51 million in fiscal 2018 to $912 million in fiscal 2025, up 51.1% a year; it rose in 7 of 7 years; it never fell from a peak; net income was positive in 2 of 8 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Inspire Medical Systems, Inc.'s diluted share count grew about 2.0% a year, and dividends and buybacks returned about 64% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 7 sales (4 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-10-16 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Inspire Medical Systems, Inc. earned about 19 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 86 cents per dollar of everything the company owns. Leverage: it owed about 14 cents per dollar of assets, and net share issuance: its share count shrank 2.6% over the year (the filed statements).

From the record

Inspire Medical Systems, Inc.'s standing among 109 graded names in its industry family: revenue of $912 million in fiscal 2025 ranks in the top 20% by size; a net margin of 15.9% ranks in the top 12%; revenue growth of 30.8% a year over the last 3 filed years ranks in the top 24% (its annual reports).

From the record

Inspire Medical Systems, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Herbert, Timothy P. (CEO and President, as filed), filing under that title since 2018-05-02, 8.5 years (top 29% of its family); the 17 officers and directors filing in the last fifteen months have been on the record a median of 5.8 years (top 47%); 10 officer or director changes were reported on Form 8-K since 2023-11-13, against the 17 people in charge now (bottom 43%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Inspire Medical Systems, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $105 million against no long-term debt tagged leaves 11.6% of its assets as net cash, top 49% of its family; cash from operations less capital spending is 8.6% of revenue (top 25%); a gross margin of 85.4% (top 6%); research spending of 11.3% of revenue (bottom 49%) (its annual report).

From the record

Inspire Medical Systems, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 30.8% a year over the last three filed years against 51.1% over all 8, slowing (bottom 13% of its family); the newest year grew 13.6% (bottom 50%); research spending grew 14.5% a year (top 29%); capital spending grew 61.7% a year (top 6%) (its annual reports). Inspire Medical Systems, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Inspire Medical Systems, Inc.'s newest year against its own record: revenue of $912 million in fiscal 2025 came in 19% below the $1.1 billion its prior three years' pace pointed to (bottom 23% of its family); net income of $145 million against a prior three-year average of $4 million (top 1%); a net margin of 15.9% against -2.6% before (top 36%) (its annual reports).